Application Information

This drug has been submitted to the FDA under the reference 021880/001.

Names and composition

"REVLIMID" is the commercial name of a drug composed of LENALIDOMIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021880/001 REVLIMID LENALIDOMIDE CAPSULE/ORAL 5MG
021880/002 REVLIMID LENALIDOMIDE CAPSULE/ORAL 10MG
021880/003 REVLIMID LENALIDOMIDE CAPSULE/ORAL 15MG
021880/004 REVLIMID LENALIDOMIDE CAPSULE/ORAL 25MG
021880/005 REVLIMID LENALIDOMIDE CAPSULE/ORAL 2.5MG
021880/006 REVLIMID LENALIDOMIDE CAPSULE/ORAL 20MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021880/001 REVLIMID LENALIDOMIDE CAPSULE/ORAL 5MG
021880/002 REVLIMID LENALIDOMIDE CAPSULE/ORAL 10MG
021880/003 REVLIMID LENALIDOMIDE CAPSULE/ORAL 15MG
021880/004 REVLIMID LENALIDOMIDE CAPSULE/ORAL 25MG
021880/005 REVLIMID LENALIDOMIDE CAPSULE/ORAL 2.5MG
021880/006 REVLIMID LENALIDOMIDE CAPSULE/ORAL 20MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved